Bioseal Dural Sealing Study BIOS-14-001

Clinical trial NCT03110783 · COMPLETED

Trial details

NCT number: NCT03110783
Sponsor: Guangzhou Bioseal Biotechnology Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Benign Tumors Malignant Tumors Vascular Malformation

Start date: 2017-09-14
Primary completion: 2019-09-20
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.